BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9449399)

  • 1. Acute effects of blood pressure elevation on insulin clearance in normotensive healthy subjects.
    O'Callaghan CJ; Komersova K; Louis WJ
    Hypertension; 1998 Jan; 31(1):104-9. PubMed ID: 9449399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism.
    Buchanan TA; Thawani H; Kades W; Modrall JG; Weaver FA; Laurel C; Poppiti R; Xiang A; Hsueh W
    J Clin Invest; 1993 Aug; 92(2):720-6. PubMed ID: 8349811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm.
    Sakai K; Imaizumi T; Masaki H; Takeshita A
    Hypertension; 1993 Jul; 22(1):67-73. PubMed ID: 8319994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity.
    Haastrup AT; Stepniakowski KT; Goodfriend TL; Egan BM
    Hypertension; 1998 Oct; 32(4):693-8. PubMed ID: 9774365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.
    Danuser H; Weiss R; Abel D; Walter B; Scholtysik G; Mettler D; Studer UE
    J Urol; 2001 Aug; 166(2):714-20. PubMed ID: 11458123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects.
    Kern W; Fittje A; Fohr W; Kerner W; Born J; Fehm HL
    Exp Clin Endocrinol Diabetes; 2000; 108(8):498-505. PubMed ID: 11149624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin II on insulin sensitivity: a placebo-controlled study.
    Morris AD; Petrie JR; Anderson J; Connell JM; Donnelly R
    Clin Sci (Lond); 1993 Oct; 85(4):431-6. PubMed ID: 8222508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
    Weyer C; Tataranni PA; Snitker S; Danforth E; Ravussin E
    Diabetes; 1998 Oct; 47(10):1555-61. PubMed ID: 9753292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential hypertension is associated with decreased insulin clearance and insulin resistance.
    Lender D; Arauz-Pacheco C; Adams-Huet B; Raskin P
    Hypertension; 1997 Jan; 29(1 Pt 1):111-4. PubMed ID: 9039089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
    Lembo G; Iaccarino G; Rendina V; Volpe M; Trimarco B
    Hypertension; 1994 Oct; 24(4):429-38. PubMed ID: 7916334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans.
    Fliser D; Schaefer F; Schmid D; Veldhuis JD; Ritz E
    Hypertension; 1997 Nov; 30(5):1156-61. PubMed ID: 9369270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects.
    Morris AD; Petrie JR; Ueda S; Connell JM; Elliott HL; Small M; Donnelly R
    Diabetes; 1994 Dec; 43(12):1445-9. PubMed ID: 7958497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness.
    Moan A; Høieggen A; Nordby G; Os I; Eide I; Kjeldsen SE
    Metabolism; 1995 Oct; 44(10):1303-7. PubMed ID: 7476289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.
    Gadegbeku CA; Shrayyef MZ; Taylor TP; Egan BM
    J Hypertens; 2006 Jul; 24(7):1383-9. PubMed ID: 16794488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins.
    Stepniakowski KT; Lu G; Miller GD; Egan BM
    Hypertension; 1997 Nov; 30(5):1150-5. PubMed ID: 9369269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.
    Chandler WL; Levy WC; Stratton JR
    Circulation; 1995 Nov; 92(10):2984-94. PubMed ID: 7586269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.